Cargando…
Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L
Cancer stem cells (CSCs) possess many characteristics associated with stem cells and are believed to drive tumor initiation. Although targeting of CSCs offers great promise for the new generation of therapeutics, lack of the effective drugable target and appropriate pharmacological reagents signific...
Autores principales: | Song, Chengli, Xu, Qiang, Jiang, Kui, Zhou, Guangyu, Yu, Xuebin, Wang, Lina, Zhu, Yuting, Fang, Liping, Yu, Zhe, Lee, Jiing-Dwan, Yu, Shi-Cang, Yang, Qingkai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741765/ https://www.ncbi.nlm.nih.gov/pubmed/26432836 |
Ejemplares similares
-
Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
por: Song, Chengli, et al.
Publicado: (2017) -
Corrigendum: Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
por: Song, Chengli, et al.
Publicado: (2017) -
DNA methylation of the promoter region of bnip3 and bnip3l genes induced by metabolic programming
por: Veron, Vincent, et al.
Publicado: (2018) -
The outer mitochondrial membrane protein TMEM11 demarcates spatially restricted BNIP3/BNIP3L-mediated mitophagy
por: Gok, Mehmet Oguz, et al.
Publicado: (2023) -
BNIP3 in Lung Cancer: To Kill or Rescue?
por: Gorbunova, Anna S., et al.
Publicado: (2020)